Pharmadrug Inc. announced that it has entered into an employment agreement with Dr. Paul Van Slyke and promoted him to Chief Scientific Officer (CSO) for all of PharmaDrug Inc. Paul previously served as CSO of Sairiyo Therapeutics on a consultancy basis.